Unsurprisingly, overexpression of USP7 and TRIP12 has been found to be associated with poor prognosis in cancers with aberrant expression of p14ARF, such as hepatocellular carcinoma (HCC) [131]. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.